Article info
PDFPapers
Reproductive ethics
Ethical considerations for choosing between possible models for using NIPD for aneuploidy detection
- Correspondence to Dr Zuzana Deans, Centre for Ethics in Medicine, School of Social and Community Medicine, University of Bristol, 39 Whatley Road, Bristol BS8 2PS, UK; zuzana.deans{at}bristol.ac.uk
Citation
Ethical considerations for choosing between possible models for using NIPD for aneuploidy detection
Publication history
- Received August 12, 2011
- Revised May 21, 2012
- Accepted May 29, 2012
- First published June 28, 2012.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
- Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
- Non-invasive prenatal testing for aneuploidy screening
- Non-invasive prenatal diagnosis: progress and potential
- Women’s choices in non-invasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England
- Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis
- Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access
- Ethics of routine: a critical analysis of the concept of ‘routinisation’ in prenatal screening
- Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing
- Non-invasive prenatal testing in mitigating concerns from invasive prenatal diagnostic testing: retrospective assessment of utility in an academic healthcare system in the US